Home
/ ImmVira
/ Competitors

ImmVira Competitors and Similar CompaniesClear all

Telix Pharmaceuticals's competitors and similar companies include AstraZeneca and Oricell Therapeutics.

	Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	Oricell Therapeutics OriCell Therapeutics (原启生物科技（上海）有限责任公司) is a biotech company specializing in tumor immunotherapy drug development.
Founding Date	Founding Date 2015	Founding Date 1999	Founding Date 2015
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations North Melbourne, AU HQ Milton, AU Sydney, AU Herstal, BE Burnaby, CA Kyoto, JP Lancy, CH see more	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations Shanghai, CN HQ
Employees	Employees 415	Employees 94,300	Employees 235% increase
Valuation ($)	Valuation ($) 4.6 b	Valuation ($) 2.7 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $803.8m (FY, 2025)	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $356m (FY, 2025)	Cost of goods $4.9b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $449m (FY, 2025)	Gross profit $54.2b (FY, 2025)	Gross profit N/A
Net income	Net income ($7.1m) (FY, 2025)	Net income $10.2b (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1b	Total funding raised $ 162m